APA (7th ed.) Citation

DA, W., Y, W., M, B., K, R., S, O., Z, H., . . . JA, R. (2014). Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an antidiabetic clinical candidate targeting GPR119. Journal of medicinal chemistry, 57(18), 7499. https://doi.org/10.1021/jm501175v

Chicago Style (17th ed.) Citation

DA, Wacker, et al. "Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119." Journal of Medicinal Chemistry 57, no. 18 (2014): 7499. https://doi.org/10.1021/jm501175v.

MLA (9th ed.) Citation

DA, Wacker, et al. "Discovery of 5-chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119." Journal of Medicinal Chemistry, vol. 57, no. 18, 2014, p. 7499, https://doi.org/10.1021/jm501175v.